Latest filing published 03 Dec 2024 for FILANA THERAPEUTICS, INC., €15k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James William Kupiec: trading record in brief
James William Kupiec discloses dealings in Filana Therapeutics, Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 23 August 2022 and the latest from 29 November 2024.
The open-market side counts 1 purchase for €61k alongside 1 sale for €15k. On balance, insiders were net buyers of €47k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 option exercise. Since January 2024: no purchases and 1 sale on the market.
The latest filing, published on 3 December 2024, reports an open-market sale of €15k in Filana Therapeutics, Inc. The latest purchase dates back some time: it was published 1,538 days ago, on 24 August 2022. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to James William Kupiec
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000 shares@ US$3.8713.7% of flowCommon StockSEC:0001437749-24-036551:0
- 1,500 shares@ US$22.0029.0% of flowCommon StockSEC:0001437749-24-012643:0
- 2,500 shares@ US$24.4457.3% of flowCommon StockSEC:0001069530-22-000039:0Canonical exit: 21 Nov 2022 (T+90)
3 of 3 declarations